"Total worldwide revenues from drugs to treat eye disorders will reach $23.8 billion in 2016, according to a new report from business information provider Visiongain," reports
the Pharma Letter. "Leading companies will achieve high sales growth from 2012 to 2022."
Read more.
No comments:
Post a Comment